Ронен Дурст

Научные публикации

• Is it time for a paradigm shift? Inclusion of APOE on genetic dyslipidemia panels
• DIAGNOSIS AND TREATMENT OF ELEVATED LIPOPROTEIN(A) IN ISRAEL: CONSENSUS STATEMENT FROM THE ISRAEL SOCIETY FOR RESEARCH, PREVENTION AND TREATMENT OF ATHEROSCLEROSIS AND ISRAEL SOCIETY FOR CLINICAL LABORATORY SCIENCES
• Endomyocardial Biopsy in Clinical Practice: The Diagnostic Yield and Insights from a 5-Year Single-Center Experience
• Variable clinical expression of a novel FLNC truncating variant in a large family
• Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia
• Calmodulinopathy Associated Long QT Syndrome, Hypertrophic Cardiomyopathy With Excessive Trabeculation in a 14-Year-Old Girl Presenting With Ventricular Fibrillation
• GCM2 p.Tyr394Ser variant in Ashkenazi Israeli patients with suspected familial isolated hyperparathyroidism
• Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study
• Efficacy, Safety, and Tolerability of Inclisiran in Patients With Homozygous Familial Hypercholesterolemia: Results From the ORION-5 Randomized Clinical Trial
• Tumor-infiltrating lymphocyte transfusion in a patient with treatment refractory triple negative breast cancer
• Long-term efficacy and safety of lerodalcibep in heterozygous familial hypercholesterolaemia: the LIBerate-HeFH trial
• Novel Association of the NOTCH Pathway Regulator MIB1 Gene With the Development of Bicuspid Aortic Valve
• Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)
• Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk
• Giant Intracardiac Lipoma: A Case Report and the Role of Multimodality Cardiac Imaging
• Step-by-step diagnosis and management of the nocebo/drucebo effect in statin-associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP)
• Mitral valve prolapse: From new mechanisms to diagnostic challenges
• Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study
• Bicuspid Aortic Valve: Genetic and Clinical Insights
• Is Bicuspid Aortic Valve Morphology Genetically Determined? A Family-Based Study
• Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
• Predictors of Hypoxemia and Related Adverse Outcomes in Patients Hospitalized with COVID-19: A Double-Center Retrospective Study
• Cost-effectiveness analysis of screening for first-degree relatives of patients with bicuspid aortic valve
• Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases - A position paper from the International Lipid Expert Panel (ILEP)
• TREATMENT OF HOMOZYGOTES OF FAMILIAL HYPERCHOLESTEROLEMIA: RECOMMENDATIONS OF THE ISRAELI SOCIETY OF ATHEROSCLEROSIS
• UPDATED ISRAELI GUIDELINES FOR THE TREATMENT OF DYSLIPIDEMIA 2020
• The impact of type of dietary protein, animal versus vegetable, in modifying cardiometabolic risk factors: A position paper from the International Lipid Expert Panel (ILEP)
• A rare frameshift mutation in the AGPAT2 gene in a family from gaza with congenital generalized lipodystrophy
• A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia
• Statin therapy in athletes and patients performing regular intense exercise - Position paper from the International Lipid Expert Panel (ILEP)
• Usefulness of Gemcabene in Homozygous Familial Hypercholesterolemia (from COBALT-1)
• Echocardiography overestimates LV mass in the elderly as compared to cardiac CT
• Surgical repair of bicuspid aortopathy at small diameters: Clinical and institutional factors
• Imaging in Cardio-oncology: An Overview of an Emerging Medical Discipline
• In search of a genetic explanation for LDLc variability in an FH family: common SNPs and a rare mutation in MTTP explain only part of LDL variability in an FH family
• Primary cilia defects causing mitral valve prolapse
• An Empirical Investigation of "Physician Congestion" in U.S. University Hospitals
• Early onset, non-rheumatic, group A streptococcal-associated myocarditis
• Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
• Correlation between coronary artery calcification by non-cardiac CT and Framingham score in young patients
• HNF1A variant, energy-reduced diets and insulin resistance improvement during weight loss: The POUNDS Lost trial and DIRECT
• Metabolic Circuit Involving Free Fatty Acids, microRNA 122, and Triglyceride Synthesis in Liver and Muscle Tissues
• APPROPRIATENESS CRITERIA FOR CARDIAC MRI - A JOINT POSITION PAPER FROM THE ISRAELI RADIOLOGICAL SOCIETY AND THE ISRAEL HEART SOCIETY
• Stepwise CaSR, AP2S1, and GNA11 sequencing in patients with suspected familial hypocalciuric hypercalcemia
• Molecular genetics of familial hypercholesterolemia in Israel-revisited
• Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration
• Managing dyslipidaemia in type 2 diabetes mellitus
• Effect of growth hormone treatment on diastolic function in patients who have developed growth hormone deficiency after definitive treatment of acromegaly
• Lymphoma of the Right Atrium and Ventricle
• Mitral valve disease--morphology and mechanisms